Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-17

Clinical Trial Update: Intranasal Capsaicin Treatment for Non-Allergic Irritant Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intranasal capsaicin for non-allergic irritant rhinitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • capsaicin (intranasal formulation) (capsaicin)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Nonallergic Irritant Rhinitis | Phase 2 | Status: COMPLETED | Results posted: 2020-08-17